High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

IntroductionAHSCT is the treatment of choice for newly diagnosed patients with transplant-eligible multiple myeloma (MM). However, considerable variability in response to autologous hematopoietic stem cell transplantation (AHSCT) results in only 50% of patients achieving complete response (CR) after...

Full description

Bibliographic Details
Main Authors: Damian Mikulski, Mateusz Nowicki, Izabela Dróźdż, Małgorzata Misiewicz, Kacper Piotr Kościelny, Karol Okoński, Kinga Krawiec, Ewelina Perdas, Agnieszka Wierzbowska, Wojciech Fendler
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
aHSCT
autologous hematopoietic stem cell transplantation
complete response
CR
MiR-223-3p
miRNA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1250355/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1250355/full

Similar Items